Chamomile and anxiety
What 2 graded rows on chamomile agree on for anxiety, and where they differ. Counted side by side, never averaged.
Consensus finder Rows from the Chamomile page, reviewed Oct 21, 2026 How it decides
What the rows agree on
Each block and row is one graded row from the Chamomile page, with its PubMed record.
Your question
Chamomile and anxiety
2 rows · 150 peopleSplit. 1 row found an improvement and 1 had mixed results.
- CGrade C× 1
- DGrade D× 1
- Rows
- 2
- Trials
- 2
- People
- 150
What the rows share
From the rowsThe best-graded row, grade C, is a randomized trial of 57 people (2009) and found an improvement.
The rows run from 57 to 93 people, published from 2009 to 2016: 2 single studies.
The rows
1 improved · 1 mixed- CGrade CGeneralised anxiety disorder symptoms · Improved
RCT · n 57 · 2009 · Outpatients with mild to moderate generalised anxiety disorder
220–1,100 mg/day (1–5 capsules, titrated) · 8 weeks
Total Hamilton Anxiety score fell more than with placebo (p=0.047); secondary measures moved the same way; adverse events were similar.
- DGrade DRelapse of generalised anxiety disorder · Mixed
RCT · n 93 · 2016 · Responders after 12 weeks of open-label chamomile in moderate to severe generalised anxiety disorder (179 enrolled)
500 mg three times daily (1,500 mg/day) · 12-week open-label phase, then 26 weeks randomised
Relapse was 15.2% with continued chamomile vs 25.5% after switching to placebo (HR 0.52, not significant); anxiety symptoms stayed significantly lower with chamomile.